Live
NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
£608,000,000
services
Contract Details
- Tender Value
- £608,000,000
- Stage
- Live
- Published
- Awarded
Timeline
Awarded
Start
Disclosed
End
Description
NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5) Tender Reference: CM/PHR/22/5686/01 Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).
Related Contracts
From This Buyer
- Adult Screening and Personalisation Digital Delivery Services
£215,163,316 ·
- Step into the NHS - Schools Programme
£65,800 ·
- Website hosting and support for hee.nhs.uk and healthcareers.nhs.uk
£168,336 ·
- NHS Login Run and Maintain 2
£30,000,000 ·
From This Supplier
In This Category
Ref: 5b2ed894-865e-46a1-9251-f9f8b92b6a85-737287 · Sourced from Contracts Finder
View source notice